title: Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
abstract: BACKGROUND
  To investigate the significance of Aurora B expression in hepatocellular carcinoma (HCC).
  
  
  METHODS
  The Aurora B and Aurora A mRNA level was measured in 160 HCCs and the paired nontumorous liver tissues by reverse transcription-polymerase chain reaction. Mutations of the p53 and β-catenin genes were analyzed in 134 and 150 tumors, respectively, by direct sequencing of exon 2 to exon 11 of p53 and exon 3 of β-catenin. Anticancer effects of AZD1152-HQPA, an Aurora B kinase selective inhibitor, were examined in Huh-7 and Hep3B cell lines.
  
  
  RESULTS
  Aurora B was overexpressed in 98 (61%) of 160 HCCs and in all 7 HCC cell lines examined. The overexpression of Aurora B was associated with Aurora A overexpression (P = 0.0003) and p53 mutation (P = 0.002) and was inversely associated with β-catenin mutation (P = 0.002). Aurora B overexpression correlated with worse clinicopathologic characteristics. Multivariate analysis confirmed that Aurora B overexpression was an independent poor prognostic factor, despite its interaction with Aurora A overexpression and mutations of p53 and β-catenin. In Huh-7 and Hep3B cells, AZD1152-HQPA induced proliferation blockade, histone H3 (Ser10) dephosphorylation, cell cycle disturbance, and apoptosis.
  
  
  CONCLUSIONS
  Aurora B overexpression is an independent molecular marker predicting tumor invasiveness and poor prognosis of HCC. Aurora B kinase selective inhibitors are potential therapeutic agents for HCC treatment.
authors.affiliation: Departments of Oncology, National Taiwan University Hospital Yun-Lin Branch, No. 360, Singjhong Village, Huwei Township, Yun-Lin County, 63252, Taiwan.
authors.forename: Zhong-Zhe
authors.initials: ZZ
authors.lastname: Lin
authors.forename: Yung-Ming
authors.initials: YM
authors.lastname: Jeng
authors.forename: Fu-Chang
authors.initials: FC
authors.lastname: Hu
authors.forename: Hung-Wei
authors.initials: HW
authors.lastname: Pan
authors.forename: Hsin-Wei
authors.initials: HW
authors.lastname: Tsao
authors.forename: Po-Lin
authors.initials: PL
authors.lastname: Lai
authors.forename: Po-Huang
authors.initials: PH
authors.lastname: Lee
authors.forename: Ann-Lii
authors.initials: AL
authors.lastname: Cheng
authors.forename: Hey-Chi
authors.initials: HC
authors.lastname: Hsu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D064107:Aurora Kinase B; D064127:Aurora Kinases; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D005260:Female; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism; D055815:Young Adult; D051176:beta Catenin / Q000235:genetics / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D012333:RNA, Messenger; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D051176:beta Catenin; C576921:AURKB protein, human; D064107:Aurora Kinase B; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases
references.citation: J Hepatol. 2009 Mar;50(3):518-27
references.pmid: 19155085
references.citation: Cancer Treat Rev. 2008 Apr;34(2):175-82
references.pmid: 18023292
references.citation: J Hepatol. 2010 Jan;52(1):63-71
references.pmid: 19913935
references.citation: Int J Oncol. 1994 Jun;4(6):1341-7
references.pmid: 21567059
references.citation: Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5368-76
references.pmid: 17875765
references.citation: Nat Rev Mol Cell Biol. 2007 Oct;8(10):798-812
references.pmid: 17848966
references.citation: Cancer Genet Cytogenet. 2003 Apr 15;142(2):129-33
references.pmid: 12699889
references.citation: Gastroenterology. 2001 Jun;120(7):1763-73
references.pmid: 11375957
references.citation: Am J Pathol. 2002 May;160(5):1831-7
references.pmid: 12000734
references.citation: Nat Rev Cancer. 2005 Jan;5(1):42-50
references.pmid: 15630414
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1309-14
references.pmid: 14745031
references.citation: J Cell Sci. 2006 Sep 1;119(Pt 17):3664-75
references.pmid: 16912073
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):417-23
references.pmid: 19190145
references.citation: Int J Cancer. 2004 Oct 20;112(1):44-50
references.pmid: 15305374
references.citation: Cancer. 2003 Jul 1;98(1):119-27
references.pmid: 12833464
references.citation: Br J Surg. 2008 May;95(5):611-9
references.pmid: 18311747
references.citation: Clin Cancer Res. 2008 Mar 15;14(6):1639-48
references.pmid: 18347165
references.citation: Hepatology. 1991 May;13(5):923-8
references.pmid: 1851494
references.citation: Cancer Res. 2006 May 15;66(10):4996-5002
references.pmid: 16707419
references.citation: Nucleic Acids Res. 1993 Mar 25;21(6):1498
references.pmid: 8464749
references.citation: Am J Pathol. 2000 Sep;157(3):763-70
references.pmid: 10980116
references.citation: J Clin Endocrinol Metab. 2005 Feb;90(2):928-35
references.pmid: 15562011
references.citation: Gastroenterology. 2002 May;122(6):1609-19
references.pmid: 12016426
references.citation: J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8
references.pmid: 12394209
references.citation: Cancer. 1988 May 15;61(10):2095-9
references.pmid: 2834037
references.citation: Nat Rev Cancer. 2004 Dec;4(12):927-36
references.pmid: 15573114
references.citation: Cancer Res. 1993 Oct 1;53(19):4691-4
references.pmid: 8402647
references.citation: J Hepatol. 2008;48 Suppl 1:S20-37
references.pmid: 18304676
references.citation: Surgery. 1996 Jul;120(1):23-9
references.pmid: 8693418
references.citation: Mol Cancer Res. 2007 Jan;5(1):1-10
references.pmid: 17259342
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Jpn J Clin Oncol. 2002 Mar;32 Suppl:S66-81
references.pmid: 11959880
references.citation: Clin Cancer Res. 2004 Mar 15;10(6):2065-71
references.pmid: 15041727
references.citation: Clin Cancer Res. 2007 Jun 15;13(12):3682-8
references.pmid: 17575233
references.citation: Gastroenterology. 2007 Jun;132(7):2557-76
references.pmid: 17570226
references.citation: Nat Genet. 1998 Oct;20(2):189-93
references.pmid: 9771714
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8625-30
references.pmid: 15173575